Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Hybridon suspends development of GEM-91 for AIDS

July 28, 1997

HIV protease inhibitors from Novartis

July 17, 1997

Ganciclovir implant effective in treating CMV retinitis

July 17, 1997

Roche rights to Viracept expanded

July 16, 1997

Genesys Pharma receives Canadian approval to commence phase I trial with antisense AIDS treatment

July 16, 1997

HIV protease inhibitor enters phase III pediatric trial

July 15, 1997

Takeda's fumagillin analogue for microsporidial infections in AIDS patients

July 14, 1997

Cel-Sci developing AIDS vaccine with broad activity

July 11, 1997

HIV-IG pharmacokinetics assessed in AIDS patients

July 11, 1997

DuPont Merck investigates new approach to potent HIV protease inhibitors

July 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...